Alexion Pharmaceuticals (France)

Effect of Eculizumab on Hemolysis and Transfusion Requirements in Patients with Paroxysmal Nocturnal Hemoglobinuria

Peter Hillmen, Claire Hall, Judith Marsh et al. · New England Journal of Medicine · 2004 · 631 citations · Full text

Myocardial Infarction and Apoptosis After Myocardial Ischemia and Reperfusion

Antti Väkevä, Azin Agah, Scott A. Rollins et al. · Circulation · 1998 · 392 citations · Full text

Pexelizumab, an Anti-C5 Complement Antibody, as Adjunctive Therapy to Primary Percutaneous Coronary Intervention in Acute Myocardial Infarction

Christopher B. Granger, Kenneth W. Mahaffey, W. Douglas Weaver et al. · Circulation · 2003 · 315 citations · Full text

Eculizumab in paroxysmal nocturnal haemoglobinuria and atypical haemolytic uraemic syndrome: 10‐year pharmacovigilance analysis

Gèrard Socié, Marie‐Pierre Caby‐Tosi, Jing L. Marantz et al. · British Journal of Haematology · 2019 · 226 citations · Full text

Klebsiella Pneumoniae, Pathology, Eculizumab Exposure +19

Xenotransplantation of transgenic pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord

Toshio Imaizumi, Karen L. Lankford, Willis V. Burton et al. · Nature Biotechnology · 2000 · 180 citations · Full text

Regenerative Medicine, Neuroregeneration, Xenotransplantation +11